genetics rheumatoid arthritis contributes biology drug discovery 
major challenge human genetics devise systematic strategy integrate disease-associated variants diverse genomic biological data sets provide insight disease pathogenesis guide drug discovery complex traits rheumatoid arthritis ra performed genome-wide association study meta-analysis total > subjects european asian ancestries ra cases controls evaluating similar million single-nucleotide polymorphisms discovered novel ra risk loci genome-wide level significance bringing total refs devised silico pipeline using established bioinformatics methods based functional annotation cis-acting expression quantitative trait loci pathway analyses--as well novel methods based genetic overlap human primary immunodeficiency haematological cancer somatic mutations knockout mouse phenotypes-to identify biological candidate genes risk loci demonstrate genes targets approved therapies ra suggest drugs approved indications may repurposed treatment ra together comprehensive genetic study sheds light fundamental genes pathways cell types contribute ra pathogenesis provides empirical evidence genetics ra can provide important information drug discovery 
